Marshall Karpel

Marshall Karpel is a Senior Scientist at Cell Signaling Technology. Prior to this, Marshall worked as a Staff Scientist at Ragon Institute of MGH, MIT and Harvard, where Marshall conducted research on overcoming germinal center blockade in antibody generation. Marshall's background includes experience in therapeutic nanoparticle design at Massachusetts Institute of Technology and biodefense research at Massachusetts General Hospital. Marshall holds a Ph.D. in Virology from Harvard Medical School and a B.S. in Biological Chemistry from Bates College.